Novartis buys Endocyte for $2.1B in latest deal under CEO Narasimhan

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 18, 2018 at 1:12 PM.

  1. #1 cafead, Oct 18, 2018 at 1:12 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Novartis will buy the Indiana-based biotech Endocyte and its experimental radiopharmaceutical drug for $2.1 billion, the Swiss pharma announced Thursday, furthering an expansion into nuclear medicine begun last year with the acquisition of Advanced Accelerator Applications.

    article source
     
    Quote

Reply to Thread